![Frontiers | Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia Frontiers | Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia](https://www.frontiersin.org/files/MyHome%20Article%20Library/1037738/1037738_Thumb_400.jpg)
Frontiers | Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
![A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/v78n0720F1.gif)
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com
GRID Plus - Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting. #drrashidsdrugupdates | Facebook
![PDF) Amisulpride ��� dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Maxine Patel - Academia.edu PDF) Amisulpride ��� dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Maxine Patel - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45997870/mini_magick20190210-1167-fv7iv9.png?1549851248)
PDF) Amisulpride ��� dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Maxine Patel - Academia.edu
![PDF] D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. | Semantic Scholar PDF] D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e1c89e82cbd44ce2c3081b80c592d13893844cd8/3-Figure2-1.png)